Back to Journals » Drug Design, Development and Therapy » Volume 13

Corrigendum

A Novel Hybrid Compound LLP2A-Alendronate Accelerates Open Fracture Healing in a Rabbit Model [Corrigendum]

       

Authors Wang Z, Zhao Y, Zhang D, Qi B, Xiao W, Hu X, Yu A 

Received 19 November 2019

Accepted for publication 19 November 2019

Published 9 December 2019 Volume 2019:13 Pages 4159—4160

DOI https://doi.org/10.2147/DDDT.S239224

Download Article [PDF] 


Wang Z, Zhao Y, Zhang D, et al. Drug Des Devel Ther. 2019;13:1077–1086.

Following a review of the article, the authors noticed errors in the main text.

Read the original article

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]